{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:24:53Z","timestamp":1786119893573,"version":"build-2736575974"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,9]]},"abstract":"<jats:p>\n                    Androgens have been suspected to be involved in the initiation of renal cell carcinoma because of a two-fold increased risk in men compared with women. To investigate the role of self-reported finasteride or oral contraceptive use in the Prostate, Lung, Colorectal, and Ovarian (PCLO) to determine whether the androgen receptor reduces renal cancer development. We query the PCLO trial for predictor variables from the baseline questionnaire and follow-up questionnaires enquiring medication use, specifically the use of 5-\u03b1 reductase inhibitors (dutasteride or finasteride) and oral contraceptive therapy. The primary outcome of this study was the incidence of renal cancer. Statistical analysis included Student\u2019s\n                    <jats:italic toggle=\"yes\">t<\/jats:italic>\n                    -test for continuous variables,\n                    <jats:italic toggle=\"yes\">\u03c7<\/jats:italic>\n                    <jats:sup>2<\/jats:sup>\n                    , or Fisher\u2019s exact tests for dichotomous or categorical variables, and multivariable analysis using Cox proportional hazards models. Eight percent (\n                    <jats:italic toggle=\"yes\">n<\/jats:italic>\n                    =6117\/73\u2009694) of men in the PCLO trial reported the use of finasteride. 52 (10.6%) of the 492 men diagnosed with renal cancer had self-reported exposure to finasteride and this was not significant in univariable analysis (52\/6169; 0.84% vs. 440\/66\u2009454; 0.67%,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    =0.12) or multivariable main effects analysis (hazard ratio: 1.12; 95% confidence interval: 0.83\u20131.5;\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    =0.47). Approximately 54% of women (\n                    <jats:italic toggle=\"yes\">n<\/jats:italic>\n                    =40\u2009997\/75\u2009989) in the PCLO trial reported the use of oral contraceptives by questionnaire. 136 (52.1%) of the 261 women diagnosed with renal cancer had self-reported exposure to oral contraceptive therapy and this was not significant in univariable analysis (136\/40\u2009997; 0.33% vs. 125\/34\u2009992; 0.36%,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    =0.36) or in multivariable main effects analysis (hazard ratio: 1.03; 95% confidence interval: 0.97\u20131.1;\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    =0.30). Self-reported use of finasteride or oral contraceptives is not associated with a reduced incidence of renal cancer.\n                  <\/jats:p>","DOI":"10.1097\/cej.0000000000000345","type":"journal-article","created":{"date-parts":[[2017,3,23]],"date-time":"2017-03-23T17:27:52Z","timestamp":1490290072000},"page":"449-452","source":"Crossref","is-referenced-by-count":3,"title":["Hormonal manipulation with finasteride or oral contraception does not influence incidence of renal cell carcinoma"],"prefix":"10.1097","volume":"27","author":[{"given":"Aashish","family":"Kabra","sequence":"first","affiliation":[{"name":"Urology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Gelfond","sequence":"additional","affiliation":[{"name":"Biostatistics, University of Texas Health Science Center San Antonio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Liss","sequence":"additional","affiliation":[{"name":"Urology"},{"name":"Department of Surgery, South Texas Veterans Healthcare System, San Antonio, Texas, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230905","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1021\/tx010042g","article-title":"Imbalance of estrogen homeostasis in kidney and liver of hamsters treated with estradiol: implications for estrogen-induced initiation of renal tumors","volume":"14","author":"Cavalieri","year":"2001","journal-title":"Chem Res Toxicol"},{"key":"R2-20230905","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.1038\/onc.2013.274","article-title":"Androgen receptor (AR) differential roles in hormone-related tumors including prostate, bladder, kidney, lung, breast and liver","volume":"33","author":"Chang","year":"2014","journal-title":"Oncogene"},{"key":"R3-20230905","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0378-5122(95)00928-E","article-title":"Cross-sectional and case-controlled analyses of the association between smoking and early menopause","volume":"22","author":"Cramer","year":"1995","journal-title":"Maturitas"},{"key":"R4-20230905","first-page":"1745","article-title":"Novel targets and therapies for metastatic renal cell carcinoma","volume":"20","author":"Feldman","year":"2006","journal-title":"Oncology (Williston Park)"},{"key":"R5-20230905","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1093\/carcin\/bgr109","article-title":"Catechol metabolites of endogenous estrogens induce redox cycling and generate reactive oxygen species in breast epithelial cells","volume":"32","author":"Fussell","year":"2011","journal-title":"Carcinogenesis"},{"key":"R6-20230905","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/j.juro.2015.03.078","article-title":"Increased expression of androgen receptor mRNA in human renal cell carcinoma cells is associated with poor prognosis in patients with localized renal cell carcinoma","volume":"194","author":"Ha","year":"2015","journal-title":"J Urol"},{"key":"R7-20230905","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.18632\/oncotarget.1833","article-title":"Hyperactivation of Akt\/mTOR and deficiency in tuberin increased the oxidative DNA damage in kidney cancer patients with diabetes","volume":"5","author":"Habib","year":"2014","journal-title":"Oncotarget"},{"key":"R8-20230905","doi-asserted-by":"crossref","first-page":"4420","DOI":"10.1158\/0008-5472.CAN-13-2681","article-title":"ASC-J9 suppresses renal cell carcinoma progression by targeting an androgen receptor-dependent HIF2alpha\/VEGF signaling pathway","volume":"74","author":"He","year":"2014","journal-title":"Cancer Res"},{"issue":"Pt 1","key":"R9-20230905","first-page":"611","article-title":"Steroid hormone receptor expression in renal cell carcinoma: an immunohistochemical analysis of 182 tumors","volume":"171","author":"Langner","year":"2004","journal-title":"J Urol"},{"key":"R10-20230905","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1161\/HYPERTENSIONAHA.113.02953","article-title":"Hypertension and obesity and the risk of kidney cancer in 2 large cohorts of US men and women","volume":"63","author":"Sanfilippo","year":"2014","journal-title":"Hypertension"},{"key":"R11-20230905","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/MAJ.0000000000000451","article-title":"Finasteride reduces microvessel density and expression of vascular endothelial growth factor in renal tissue of diabetic rats","volume":"349","author":"Tian","year":"2015","journal-title":"Am J Med Sci"},{"key":"R12-20230905","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3322\/caac.21262","article-title":"Global cancer statistics, 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"R13-20230905","doi-asserted-by":"crossref","first-page":"510.e519","DOI":"10.1016\/j.urology.2013.10.022","article-title":"The expression and evaluation of androgen receptor in human renal cell carcinoma","volume":"83","author":"Zhu","year":"2014","journal-title":"Urology"}],"container-title":["European Journal of Cancer Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00008469-201809000-00005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T19:37:44Z","timestamp":1786045064000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00008469-201809000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":13,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/cej.0000000000000345","relation":{},"ISSN":["0959-8278"],"issn-type":[{"value":"0959-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]}}}